Global BCG Vaccine Sales Market Insight 2020 by Top Companies, Region, Type and Application
出 版 商：XYZ Research
出版日期：2019/12/01
頁 數：100頁
文件格式：PDF
價 格：
USD 3,650 (Single-User License)
USD 7,200 (Global-User License)
USD 7,200 (Global-User License)
In this report,global BCG Vaccine Market will reach 342.56 Million USD by the end of 2022 with a CAGR of 4.54%
The global BCG Vaccine market is valued at 274.34 Million USD in 2017 and will reach 342.56 Million USD by the end of 2022, growing at a CAGR of 4.54% during 2017-2022.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guerin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
BCG Vaccine can be divided into two categories—Immune BCG and Therapy BCG type. Therapy BCG type production market share accounted for the highest proportion, with a figure of 94.81% in 2017, Immune BCG type account for 5.19%.
The consumption market share of global BCG Vaccine in Hospital use and Clinic use have been stable year by year, at 74.20% and 25.80% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the BCG Vaccine in the global market tends to be fixed without great changes. Among them, the BCG Vaccine market has the most promising sales prospects in Hospital use.
XYZ research center data shows that North America is the biggest contributor to the BCG Vaccine revenue market, accounted for 34.75% of the total global market with a revenue of 95.32 million USD in 2017, followed by Europe, 32.34% with a revenue of 88.72 million USD.
Market competition is not intense. Sanofi Pasteur is the largest company in the global BCG Vaccine market, accounted for 33.61% of the revenue market share in 2017, followed by Merck and Japan BCG Lab, accounted for 32.71% and 18.34% of the revenue market share in 2017.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of BCG Vaccine for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global BCG Vaccine market competition by top manufacturers/players, with BCG Vaccine sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Others
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immune BCG
Therapy BCG
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of BCG Vaccine for each application, including
Hospitals
Clinics
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
The global BCG Vaccine market is valued at 274.34 Million USD in 2017 and will reach 342.56 Million USD by the end of 2022, growing at a CAGR of 4.54% during 2017-2022.
BCG Vaccine is a vaccine primarily used against tuberculosis. Tuberculosis is a serious infection, which affects the lungs and sometimes other parts of the body, such as the bones, joints and kidneys. The bacille Calmette-Guerin (BCG) vaccine has existed for 80 years and is one of the most widely used of all current vaccines, reading >80%of neonates and infants in countries where it is part of the national childhood immunization programme.
BCG Vaccine can be divided into two categories—Immune BCG and Therapy BCG type. Therapy BCG type production market share accounted for the highest proportion, with a figure of 94.81% in 2017, Immune BCG type account for 5.19%.
The consumption market share of global BCG Vaccine in Hospital use and Clinic use have been stable year by year, at 74.20% and 25.80% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the BCG Vaccine in the global market tends to be fixed without great changes. Among them, the BCG Vaccine market has the most promising sales prospects in Hospital use.
XYZ research center data shows that North America is the biggest contributor to the BCG Vaccine revenue market, accounted for 34.75% of the total global market with a revenue of 95.32 million USD in 2017, followed by Europe, 32.34% with a revenue of 88.72 million USD.
Market competition is not intense. Sanofi Pasteur is the largest company in the global BCG Vaccine market, accounted for 33.61% of the revenue market share in 2017, followed by Merck and Japan BCG Lab, accounted for 32.71% and 18.34% of the revenue market share in 2017.
Geographically, this report split global into several key Regions, with sales (K Units), revenue (M USD), market share and growth rate of BCG Vaccine for these regions, from 2014 to 2026 (forecast), covering
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America
Global BCG Vaccine market competition by top manufacturers/players, with BCG Vaccine sales volume, Price (USD/Unit), revenue (M USD) and market share for each manufacturer/player; the top players including
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
Serum Institute of India
Intervax
GSBPL
Others
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Immune BCG
Therapy BCG
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of BCG Vaccine for each application, including
Hospitals
Clinics
Others
If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 BCG Vaccine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Immune BCG
2.1.2 Therapy BCG
2.2 Overall Market Performance(Value)
2.2.1 Immune BCG
2.2.2 Therapy BCG
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
4 Manufacturers Profiles/Analysis
4.1 Merck
4.1.1 Merck Profiles
4.1.2 Merck Product Information
4.1.3 Merck BCG Vaccine Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Merck SWOT Analysis
4.2 Sanofi Pasteur
4.2.1 Sanofi Pasteur Profiles
4.2.2 Sanofi Pasteur Product Information
4.2.3 Sanofi Pasteur BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Sanofi Pasteur SWOT Analysis
4.3 Japan BCG Lab
4.3.1 Japan BCG Lab Profiles
4.3.2 Japan BCG Lab Product Information
4.3.3 Japan BCG Lab BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Japan BCG Lab SWOT Analysis
4.4 China National Biotec
4.4.1 China National Biotec Profiles
4.4.2 China National Biotec Product Information
4.4.3 China National Biotec BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 China National Biotec SWOT Analysis
4.5 Serum Institute of India
4.5.1 Serum Institute of India Profiles
4.5.2 Serum Institute of India Product Information
4.5.3 Serum Institute of India BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Serum Institute of India SWOT Analysis
4.6 Intervax
4.6.1 Intervax Profiles
4.6.2 Intervax Product Information
4.6.3 Intervax BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Intervax SWOT Analysis
4.7 GSBPL
4.7.1 GSBPL Profiles
4.7.2 GSBPL Product Information
4.7.3 GSBPL BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 GSBPL SWOT Analysis
4.8 Others
4.8.1 Others Profiles
4.8.2 Others Product Information
4.8.3 Others BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Others SWOT Analysis
5 Market Performance for Manufacturers
5.1 Global BCG Vaccine Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global BCG Vaccine Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global BCG Vaccine Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global BCG Vaccine Market Assessment by Regions (2014-2020)
7.1 Global BCG Vaccine Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global BCG Vaccine Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global BCG Vaccine Price (USD/Unit) by Regions 2014-2020
7.4 Global BCG Vaccine Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA BCG Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Hospitals Industry
11.2 Clinics Industry
11.3 Others Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global BCG Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global BCG Vaccine Sales (K Units) and Growth Rate 2021-2026
12.1.3 China BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Immune BCG
12.2.3 Therapy BCG
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Hospitals
12.3.3 Clinics
12.3.4 Others
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global BCG Vaccine Price (USD/Unit) Trend 2021-2026
12.4.2 Global BCG Vaccine Gross Profit Trend 2021-2026
13 Conclusion
1 Executive Summary
1.1 Definition and Specification
1.2 Report Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.2.3 Type Overview
1.2.4 Application Overview
1.3 Industrial Chain
1.3.1 BCG Vaccine Overall Industrial Chain
1.3.2 Upstream
1.3.3 Downstream
1.4 Industry Situation
1.4.1 Industrial Policy
1.4.2 Product Preference
1.4.3 Economic/Political Environment
1.5 SWOT Analysis
2 Market Analysis by Types
2.1 Overall Market Performance(Volume)
2.1.1 Immune BCG
2.1.2 Therapy BCG
2.2 Overall Market Performance(Value)
2.2.1 Immune BCG
2.2.2 Therapy BCG
3 Product Application Market
3.1 Overall Market Performance (Volume)
3.1.1 Hospitals
3.1.2 Clinics
3.1.3 Others
4 Manufacturers Profiles/Analysis
4.1 Merck
4.1.1 Merck Profiles
4.1.2 Merck Product Information
4.1.3 Merck BCG Vaccine Sales, Sales Value(Million USD), Price and Gross Profit
4.1.4 Merck SWOT Analysis
4.2 Sanofi Pasteur
4.2.1 Sanofi Pasteur Profiles
4.2.2 Sanofi Pasteur Product Information
4.2.3 Sanofi Pasteur BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.2.4 Sanofi Pasteur SWOT Analysis
4.3 Japan BCG Lab
4.3.1 Japan BCG Lab Profiles
4.3.2 Japan BCG Lab Product Information
4.3.3 Japan BCG Lab BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.3.4 Japan BCG Lab SWOT Analysis
4.4 China National Biotec
4.4.1 China National Biotec Profiles
4.4.2 China National Biotec Product Information
4.4.3 China National Biotec BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.4.4 China National Biotec SWOT Analysis
4.5 Serum Institute of India
4.5.1 Serum Institute of India Profiles
4.5.2 Serum Institute of India Product Information
4.5.3 Serum Institute of India BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.5.4 Serum Institute of India SWOT Analysis
4.6 Intervax
4.6.1 Intervax Profiles
4.6.2 Intervax Product Information
4.6.3 Intervax BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.6.4 Intervax SWOT Analysis
4.7 GSBPL
4.7.1 GSBPL Profiles
4.7.2 GSBPL Product Information
4.7.3 GSBPL BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.7.4 GSBPL SWOT Analysis
4.8 Others
4.8.1 Others Profiles
4.8.2 Others Product Information
4.8.3 Others BCG VaccineSales, Sales Value (Million USD), Price and Gross Profit
4.8.4 Others SWOT Analysis
5 Market Performance for Manufacturers
5.1 Global BCG Vaccine Sales (K Units) and Market Share by Manufacturers 2014-2020
5.2 Global BCG Vaccine Revenue (M USD) and Market Share by Manufacturers 2014-2020
5.3 Global BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
5.4 Global BCG Vaccine Gross Margin of Manufacturers 2014-2020
5.5 Market Concentration
6 Regions Market Performance for Manufacturers
6.1 China Market Performance for Manufacturers
6.1.1 China BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.1.2 China BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.1.3 China BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.1.4 China BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.2.2 USA BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.2.3 USA BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.2.4 USA BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.3.2 Europe BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.3.3 Europe BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.3.4 Europe BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.4.2 Japan BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.4.3 Japan BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.4.4 Japan BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.5.2 Korea BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.5.3 Korea BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.5.4 Korea BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.6.2 India BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.6.3 India BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.6.4 India BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.7.2 Southeast Asia BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.7.3 Southeast Asia BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.7.4 Southeast Asia BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America BCG Vaccine Sales (K Units) and Share of Manufacturers 2014-2020
6.8.2 South America BCG Vaccine Revenue (M USD) and Share of Manufacturers 2014-2020
6.8.3 South America BCG Vaccine Price (USD/Unit) of Manufacturers 2014-2020
6.8.4 South America BCG Vaccine Gross Margin of Manufacturers 2014-2020
6.8.5 Market Concentration
7 Global BCG Vaccine Market Assessment by Regions (2014-2020)
7.1 Global BCG Vaccine Sales (K Units) and Market Share by Regions 2014-2020
7.2 Global BCG Vaccine Revenue (M USD) and Market Share by Regions 2014-2020
7.3 Global BCG Vaccine Price (USD/Unit) by Regions 2014-2020
7.4 Global BCG Vaccine Gross Margin by Regions 2014-2020
8 Development Trend for Regions
8.1 Global BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.2 China BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.3 USA BCG Vaccine Sales and Growth, Sales Value and Growth Rate2014-2020
8.4 Europe BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.5 Japan BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.6 Korea BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.7 India BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
8.8 Southeast Asia BCG Vaccine Sales and Growth, Sales Value and Growth Rate 2014-2020
9 Upstream Source, Technology and Cost
9.1 Upstream Source
9.2 Technology
9.3 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution
11 Consumer Analysis
11.1 Hospitals Industry
11.2 Clinics Industry
11.3 Others Industry
12 Market Forecast 2021-2026
12.1 Sales (K Units), Revenue (M USD), Market Share and Growth Rate 2021-2026
12.1.1 Global BCG Vaccine Sales (K Units), Revenue (M USD) and Market Share by Regions 2021-2026
12.1.2 Global BCG Vaccine Sales (K Units) and Growth Rate 2021-2026
12.1.3 China BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.4 USA BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.5 Europe BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.6 Japan BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.7 Korea BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.8 India BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.9 Southeast Asia BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.1.10 South America BCG Vaccine Sales (K Units), Revenue (M USD) and Growth Rate 2021-2026
12.2 Sales (K Units), Revenue (M USD) Forecast by Types 2021-2026
12.2.1 Overall Market Performance
12.2.2 Immune BCG
12.2.3 Therapy BCG
12.3 Sales (K Units) Forecast by Application 2021-2026
12.3.1 Overall Market Performance
12.3.2 Hospitals
12.3.3 Clinics
12.3.4 Others
12.4 Price (USD/Unit) and Gross Profit
12.4.1 Global BCG Vaccine Price (USD/Unit) Trend 2021-2026
12.4.2 Global BCG Vaccine Gross Profit Trend 2021-2026
13 Conclusion
